Follow
Katherine McNamara (Pogrebniak)
Katherine McNamara (Pogrebniak)
MD/PhD Student, Stanford University
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Clonal replacement of tumor-specific T cells following PD-1 blockade
KE Yost, AT Satpathy, DK Wells, Y Qi, C Wang, R Kageyama, ...
Nature medicine 25 (8), 1251-1259, 2019
10762019
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 8760, 2015
5052015
A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds
A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ...
Cell 167 (1), 260-274. e22, 2016
4382016
Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing
T Baslan, J Kendall, K Volyanskyy, K McNamara, H Cox, S D'Italia, ...
elife 9, e51480, 2020
652020
Harnessing tumor evolution to circumvent resistance
KL Pogrebniak, C Curtis
Trends in Genetics 34 (8), 639-651, 2018
582018
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response
KL McNamara, JL Caswell-Jin, R Joshi, Z Ma, E Kotler, GR Bean, ...
Nature cancer 2 (4), 400-413, 2021
562021
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, J Ding, ...
Nature communications 10 (1), 657, 2019
542019
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
SA Hurvitz, JL Caswell-Jin, KL McNamara, JJ Zoeller, GR Bean, ...
Nature communications 11 (1), 5824, 2020
452020
Violation of the ISNT rule in nonglaucomatous pediatric optic disc cupping
AE Pogrebniak, B Wehrung, KL Pogrebniak, RK Shetty, P Crawford
Investigative Ophthalmology & Visual Science 51 (2), 890-895, 2010
392010
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer, Nat. Commun.(2015)
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
10
Transcriptome and genome evolution during HER2-amplified breast neoplasia
P Lu, J Foley, C Zhu, K McNamara, K Sirinukunwattana, S Vennam, ...
Breast Cancer Research 23, 1-15, 2021
32021
Molecular modeling of functional domain of ABCA4: Towards understanding the genotype-to-phenotype relationships in Stargardt’s disease
Y Sergeev, K Pogrebniak, B Falsini, W Zein, K Goetz, J Huang, C Peeler, ...
Investigative Ophthalmology & Visual Science 54 (15), 1325-1325, 2013
12013
Commentary on “Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia” Xu X …
K McNamara, AC Picel
CardioVascular and Interventional Radiology 45 (12), 1810-1811, 2022
2022
The diagnostic value of cytology in parotid Warthin's tumors: International multicenter series.
L Liew, K McNamara
Wiley, 2020
2020
Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the …
JL Caswell-Jin, KL McNamara, J Dering, HW Chen, R Dichmann, A Perez, ...
Cancer research (Chicago, Ill.) 80 (4_Supplement), P4-P4-07-01, 2020
2020
Abstract P4-10-12: Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial …
KL McNamara, JL Caswell-Jin, Z Ma, JJ Zoeller, M Kriner, Z Zhou, ...
Cancer Research 80 (4_Supplement), P4-10-12-P4-10-12, 2020
2020
Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial
JL Caswell-Jin, KL McNamara, J Dering, HW Chen, R Dichmann, A Perez, ...
CANCER RESEARCH 80 (4), 2020
2020
Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial Profiler
KL McNamara, JL Caswell-Jin, Z Ma, JJ Zoeller, M Kriner, Z Zhou, ...
CANCER RESEARCH 80 (4), 2020
2020
Quantifying Tumor Evolutionary Dynamics and Predictors of Response in HER2-Positive Breast Cancer Treated with Targeted Therapy
KL McNamara
Stanford University, 2020
2020
Abstract P3-06-01: Clonal evolution and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, CJ Suarez, ...
Cancer Research 79 (4_Supplement), P3-06-01-P3-06-01, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20